Navigation Links
NHP Reports 2009 First Quarter Results
Date:5/7/2009

f 6.25% due in February 2013 for $25.4 million.

2009 GUIDANCE

We are increasing by $0.02 per share the low end of our full-year 2009 recurring diluted FFO guidance of $2.20 per share to $2.22 per share and are increasing the high end of the range by $0.01 per share of $2.25 per share to $2.26 per share. We are also increasing by $0.02 per share the low end of our full-year 2009 recurring diluted FAD guidance of $2.18 per share to $2.20 per share and are increasing the high end of the range by $0.01 per share of $2.23 per share to $2.24 per share. Our guidance includes the recent retirement of $30.0 million of senior notes and excludes any acquisitions, investments, impairments or capital transactions occurring in 2009. Current guidance also assumes no material changes to the Hearthstone lease nor the recognition of any supplemental rent previously or prospectively deferred. Beginning in 2009, certain costs associated with acquisitions which were previously capitalized are now required to be expensed. While our guidance does not assume any acquisitions, we will incur certain costs that will be expensed for any acquisitions we may make and those costs could be material.

CONFERENCE CALL INFORMATION

We have scheduled a conference call and webcast on Friday, May 8, 2009 at 8:30 a.m. Pacific time (11:30 a.m. Eastern time) in order to present our performance and operating results for the quarter ended March 31, 2009. The conference call is accessible by dialing 866-700-5192 and referencing conference ID number 36865441 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is 617-213-8833. The earnings release and any additional financial information that may be discussed on the conference call will also be available at the same location on o
'/>"/>

SOURCE Nationwide Health Properties, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
2. PLC Systems Reports First Quarter 2009 Results
3. Perrigo Reports Record Third Quarter
4. Symmetry Medical Reports First Quarter 2009 Financial Results
5. Orchid Cellmark Reports Improved First Quarter 2009 Financial Results
6. Labopharm Reports Results for First Quarter Fiscal 2009
7. Isis Reports Strong Financial Results and Highlights for First Quarter of 2009
8. Cornerstone Therapeutics Reports First Quarter 2009 Financial Results
9. Stereotaxis Reports First Quarter 2009 Financial Results
10. Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
11. The Ensign Group Reports First Quarter 2009 Earnings of $0.38 per Share; Reaffirms 2009 Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Launched today on the iTunes App Store, ... care coordination tool designed to make tracking and sharing ... for family members and caregivers (e.g. physicians home care ... caregiver or home health aide providing care for a ... records, goals, schedules, and even final plans in one ...
(Date:11/21/2014)... November 21, 2014 TruDenta, the creator ... headaches and other jaw-related symptoms, has reported a ... from chronic head pain, neck pain, TMJ (temporomandibular joint) ... year we have seen a 52% increase in the ... of over 300 doctors and their teams in 47 ...
(Date:11/21/2014)... Los Angeles, CA (PRWEB) November 21, 2014 ... coding reference for the dental practice. It includes everything ... pages . , Procedure Coding with CDT , CDT ... services provided from January 1, 2014 - December 31, ... to report procedures and services on dental claims. There ...
(Date:11/21/2014)... TopConsumerReviews.com recently awarded their highest ... in the relief of depression symptoms. ... sadness and depression each year and are unable ... prescription drugs can produce worse side effects than ... and require regular follow-up visits with a doctor. ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 According to ... issued on June 11th, 2014, the inflating system found ... when the airbag inflates. The force of inflation may ... and the metal shards may pierce the airbag’s fabric ... cabin. , According to a Bloomberg Business Week ...
Breaking Medicine News(10 mins):Health News:Comprehensive Senior Care Application Launched on Apple App Store 2Health News:National Rise In Patients Seeking Headache Relief 2Health News:PMIC Announces CDT PLUS! 2015, the Ultimate Coding Reference for Dentists and Oral Surgeons 2Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3
... have, for the first time, taken adult stem cells and ... human jaw.They say the groundbreaking work may one day //lead ... suffer from temporomandibular disorders. ,The study started with ... these cells can be coaxed to become any other type ...
... the last half century, and officials at the ... be diagnosed with it this year.,The study, which analyzed ... ages of 30 and 50,// found what the researchers ... tanning can be dangerous to healthy skin. ,Melanoma ...
... and observational studies previously conducted in elderly populations ... were performed before intracoronary stents and use of ... Dr. Hanoch Hod, of Chaim Sheba Medical //Center ... consecutive patients aged 70 or older treated for ...
... hormone may help patients in treating a rare disorder ... metabolic abnormalities.The study's author found that the results of ... role of leptin in common metabolic conditions such as ... her colleagues found that a lab-engineered version of leptin, ...
... control to limit women's periods ,Seasonale, a new drug ... reduce the number of women's periods to four a year ... pills, but for longer spans of time.// ,Seasonale ... ,"For women who desire prevention of pregnancy and are comfortable ...
... milk chocolate, which is most commonly used in candy ... They found the same discouraging result among patients who ... suggest that milk and other dairy products somehow discourage ... chocolate. Only subjects who ate dark chocolate showed a ...
Cached Medicine News:Health News:Solarium use is associated with an increased risk of skin cancer 2Health News:Angioplasty plus stenting better than thrombolysis for elderly patients with AMI, 2Health News:Obesity Hormone -' Leptin' may treat Metabolic Disorder 2Health News:New birth control to limit women's periods 2Health News:When it comes to health, all chocolates not the same. 2
(Date:11/21/2014)... GABLES, Fla. , Nov. 20, 2014   ... to become the first U.S. commercial producer of Molybdenum-99 ... a contract with INVAP to design its ... Fla. Mo-99 is the parent isotope of ... medicine procedures worldwide. In 2012, Congress passed legislation making ...
(Date:11/18/2014)... LAWRENCE, Mass. , Nov. 18, 2014 /PRNewswire/ ... NXTM ), a leading manufacturer of innovative ... its new  Streamline® Express dialyzer for the ... blood tubing set, which is designed to reduce ... and to reduce the number of touch point ...
(Date:11/18/2014)... Investor-Edge has initiated coverage on the following equities: ... GERN ), Tekmira Pharmaceuticals Corporation (NASDAQ: ... and XOMA Corporation (NASDAQ: XOMA ). Free research ... . The US markets on Monday, November 17, ... Industrial Average finished at 17,647.75, up 0.07% and the NASDAQ ...
Breaking Medicine Technology:Coqui RadioPharmaceuticals Inks Deal With INVAP 2NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5
... 2011 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... featured in one oral presentation and four poster presentations at ... (AAN) in Honolulu, Hawaii April 9-16, 2011. A ... abstracts can be accessed at the AAN website at ...
... Inc. (Nasdaq: MYL ) today announced that its ... U.S. Food and Drug Administration (FDA) for its Abbreviated New ... mg and 400 mg, the generic version of Pfizer,s Neurontin ... shingles. Gabapentin Capsules had U.S. sales of ...
Cached Medicine Technology:MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology 2MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology 3MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology 4
The first instrumentation to automate and efficiently manage the slide labeling process. Proven technology automatically feeds, prints and collates slides sequentially. Extensive data customization, ...
... ISI offers instrument cleaning brushes ... diameters and composition. The long, ... cannulas and tubing. The smallest ... micros. The brass and stainless ...
... wall-mounted organizer with a complete set of micro ... The Micro Nest makes it easier for technicians ... task. These small instrument cleaning brushes from ISI ... as cannulas. ISI Micro Brushes are available in ...
... Instra-Glide Soak is the non-silicone ... instruments by allowing parts to ... , ,Instra-Glide Soak is water-soluble ... without getting sticky or gummy. ...
Medicine Products: